Assyro AI

Orange Book product · Generic (ANDA)

TIROFIBAN HYDROCHLORIDE

TIROFIBAN HYDROCHLORIDE

Generic (ANDA)ANDA 216379TE APRX EUGIA PHARMA

At a glance

May 01, 2023

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 01, 2023

    3 yr 2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

TIROFIBAN HYDROCHLORIDE

Strength

EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

AP

Application

ANDA 216379

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of TIROFIBAN HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.